Welcome to our dedicated page for Fidelis Insurance Holdings SEC filings (Ticker: FIHL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Fidelis Insurance Holdings Limited (FIHL) SEC filings page on Stock Titan provides access to the company’s U.S. regulatory disclosures as a foreign private issuer. Fidelis, a Bermuda-headquartered global specialty insurer and reinsurer, files an annual report on Form 20-F and frequent current reports on Form 6-K with the Securities and Exchange Commission. These filings incorporate press releases, consolidated financial statements, management’s discussion and analysis, and investor presentations related to the Group’s Insurance and Reinsurance segments.
Through these documents, investors can review how Fidelis reports segment performance, including gross premiums written, net premiums earned, combined ratios, catastrophe and large losses, and prior-year reserve development for its Insurance and Reinsurance businesses. The filings also describe the impact of specific events, such as California wildfires or aviation-related litigation, on loss ratios and underwriting income.
Fidelis uses its SEC filings to disclose capital management and financing activities, including share repurchase programs, dividend policies and declarations, and the issuance of subordinated notes under an effective shelf registration statement on Form F-3. Certain Form 6-K reports specify that the enclosed financial statements and MD&A are incorporated by reference into the company’s registration statements on Form S-8 and Form F-3.
On Stock Titan, AI-powered tools summarize lengthy FIHL filings so readers can quickly understand key points from Form 20-F and Form 6-K reports, including trends in underwriting performance, capital allocation, and relationships with entities such as The Fidelis Partnership. Users can also track how management commentary and risk disclosures evolve over time across multiple reporting periods.
Because Fidelis is active in specialty insurance and reinsurance, its filings are particularly relevant for those analyzing catastrophe exposure, reserve development, and the interaction between underwriting results, capital markets transactions, and external risk transfer structures such as catastrophe bonds.
Fidelis Insurance Holdings Limited has entered into a definitive agreement to repurchase all remaining common shares held by founding shareholder CVC Falcon Holdings Limited for an aggregate purchase price of
Management highlights that the repurchase price is below the company’s year-end diluted book value per common share of
Fidelis Insurance Holdings reported a sharp turnaround in the fourth quarter of 2025, with net income of
For 2025, the company generated net income of
The company returned
Fidelis Insurance Holdings Limited is expanding its capital return to shareholders. The board increased the current common share repurchase authorization to $400 million and declared a quarterly dividend of $0.15 per common share, payable on March 27, 2026 to shareholders of record on March 16, 2026.
The company highlights that it returned $313.7 million to shareholders in the year ended December 31, 2025, including repurchasing 15,184,976 common shares for $261.4 million and paying $52.3 million in dividends. Management describes repurchases and dividends as part of a broader capital management strategy alongside pursuing attractive underwriting opportunities.
Fidelis Insurance Holdings Limited received an updated ownership report from investment entities linked to CVC. As of December 31, 2025, CVC Falcon Holdings Limited directly held 8,597,170 common shares of Fidelis, which the filing states represents 8.3% of the common share class.
The percentage ownership is based on 103,026,764 common shares outstanding as of September 30, 2025. CVC Falcon Holdings Limited is wholly owned by funds managed by CVC Capital Partners VI Limited, which may be deemed to share beneficial ownership, although it expressly disclaims beneficial ownership for certain legal purposes.
Fidelis Insurance Holdings Ltd disclosed that investment firm Crestview and its related entities collectively report beneficial ownership of 14,251,474 common shares, or 13.8% of the company’s common equity.
This percentage is based on 103,026,764 common shares outstanding as of September 30, 2025, as reported in a prior Form 6-K. All Crestview entities report shared voting and shared dispositive power rather than sole control, and each disclaims beneficial ownership beyond its economic interest.
Fidelis Insurance Holdings Ltd disclosed that investor Leon G. Cooperman beneficially owns 7,041,751 common shares, representing about 6.8% of the company. This stake is held through Omega Capital Partners, L.P., a UTMA account for his grandchild, and an individual retirement account.
The ownership percentage is based on 103,026,764 common shares outstanding as of September 30, 2025. Cooperman reports sole voting and dispositive power over all 7,041,751 shares and certifies the holdings are not intended to change or influence control of Fidelis Insurance.
FIHL filed a Form 144 indicating an intended sale of restricted stock under Rule 144. The filing covers the planned sale of 9,204 common shares through broker Computershare, with an aggregate market value of $173,955.60, on the NYSE. The filing notes that there were 103,026,764 common shares outstanding at the time referenced.
The shares to be sold come from stock-based compensation. The seller acquired 578 common shares on 06/30/2024 and 8,626 common shares on 01/03/2025, both through the vesting of stock awards from the issuer as compensation. By signing the notice, the seller represents that they are not aware of any undisclosed material adverse information about FIHL.
A shareholder of FIHL has filed a Form 144 notice to sell up to 9,204 common shares through broker Computershare on or about November 19, 2025 on the NYSE. The filing lists 99,004,169 shares of the issuer’s common stock as outstanding. The shares to be sold were acquired by the filer via vesting of stock awards, including 578 shares that vested on June 30, 2024 and 8,626 shares that vested on January 3, 2025 as compensation. By signing the notice, the seller represents that they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.
Fidelis Insurance Holdings Limited submitted a Form 6-K to provide investors with materials related to its results for the three and nine months ended September 30, 2025. The company issued a press release, detailed consolidated financial statements, and a management’s discussion and analysis, all dated November 12, 2025.
The filing also includes a company slide presentation to accompany these results. The Form 6-K specifies that the information in the management’s discussion and analysis is incorporated by reference into Fidelis Insurance’s existing registration statements on Form S-8 and Form F-3, making it part of those offering documents from the filing date unless later superseded.
Fidelis Insurance Holdings Limited declared a cash dividend of $0.15 per share. The Board approved the payout, which is payable on December 23, 2025, to common shareholders of record on December 10, 2025.
This announcement sets the eligibility and payment dates for the distribution to shareholders. The company will disburse cash to holders of its common shares who are on the register as of the record date.